Essential phospholipids for nonalcoholic fatty liver disease associated with metabolic syndrome: A s

• 作 者: Asad Izziddin Dajani Branko Po
• 机 构: ADSC,Sanofi-AventisDeutschlandGmbH
• 出 处: 世界临床病例杂志
• 发表日期: 2020年21期
• 关键词: Non-alcoholic fatty liver disease DIABETES OBESITY Metabolic syndrome Essential

BACKGROUND Essential phospholipids(EPL)are used for the supportive treatment of nonalcoholic fatty liver disease(NAFLD),but data are mostly from small-scale studies.AIM To evaluate the efficacy of EPL treatment in adult patients with NAFLD and type 2 diab